Alliofil

Leaflet attached to the packaging: patient information

ALLIOFIL

Allii sativi bulbus + Urticae folium
200 mg + 53.5 mg
enteric-coated tablet

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor, pharmacist, or nurse.

• This leaflet should be kept in case it needs to be read again.
• If advice or additional information is needed, a pharmacist should be consulted.
• If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. See section 4.
• If there is no improvement or the patient feels worse, they should contact their doctor.

Table of contents of the leaflet:

• 1. What is Alliofil and what is it used for
• 2. Important information before taking Alliofil
• 3. How to take Alliofil
• 4. Possible side effects
• 5. How to store Alliofil
• 6. Package contents and other information
• 1. What is Alliofil and what is it used forAlliofil is a traditional herbal medicinal product intended for use in specific indications resulting solely from its long-term use. Traditionally, Alliofil is used preventively and as a supportive treatment for mild upper respiratory tract infections (common cold). If there is no improvement or the patient feels worse, they should contact their doctor.
• 2. Important information before taking AlliofilWhen not to take Alliofil

Warnings and precautions

During the use of Alliofil, sulfur compounds are excreted through the skin with sweat and through the lungs. This causes a change in the smell of the skin and breath.
Children and adolescents
No studies have been conducted on the safety of using the medicine in children and adolescents.
The use of the medicine in adolescents under 18 years of age requires prior consultation with a doctor.
Alliofil and other medicines
The doctor should be informed about all medicines currently being taken or recently taken, even those that are available without a prescription. So far, no interactions with other medicines have been found. However, there is a possibility of interaction with non-steroidal anti-inflammatory drugs. Alliofil may enhance the effect of anticoagulant and antiplatelet medicines.
Taking Alliofil with food and drink
It is recommended to take the medicine after eating. The tablets should be swallowed whole.
Pregnancy and breastfeeding
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Due to the lack of data confirming safety, the use of the medicine during pregnancy is not recommended. It is also not recommended during breastfeeding, as the sulfur compounds of garlic pass into breast milk, causing a change in its smell.
Driving and using machines
Taking the medicine does not affect the ability to drive vehicles or operate machinery.

• 3. How to take Alliofil

This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor, pharmacist, or nurse. In case of doubt, a doctor or pharmacist should be consulted.
For the prevention of upper respiratory tract infections: adults 3 times a day, 1 tablet.
As a supportive treatment for mild upper respiratory tract infections (common cold): adults 3 times a day, 1 to 3 tablets. The medicine should be taken after main meals. The tablets should not be chewed.
Duration of use: For preventive purposes, the medicine can be used without consulting a doctor for up to 6 months. When using the medicine for therapeutic purposes in common cold, if symptoms do not improve after 7 days, a doctor should be consulted.
Use in children and adolescents
Due to the lack of data confirming safety, the use of the medicine in children is not recommended. In adolescents, the use of the medicine is allowed after prior consultation with a doctor.
Taking a higher dose of Alliofil than recommended
There is no data on symptoms of overdose. Overdose increases the risk of occurrence and severity of side effects.
Missing a dose of Alliofil
A double dose should not be taken to make up for a missed tablet.
Stopping the use of Alliofil
In case of any further doubts related to the use of the medicine, a doctor or pharmacist should be consulted.

• 4.Possible side effectsLike all medicines, Alliofil can cause side effects, although not everybody gets them. During use, it is possible to experience respiratory and skin allergic reactions, as well as gastrointestinal disorders. If any of the side effects worsen or any side effects not listed in the leaflet occur, a doctor or pharmacist should be informed.

Reporting suspected side effects

After the medicinal product has been authorized, it is important to report any suspected side effects. This allows for continuous monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals should report any suspected side effects via the Department for the Monitoring of Adverse Reactions to Medicinal Products, Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, Al. Jerozolimskie 181C, 02-222 Warszawa, tel. 48 22 49 21 301, fax 48 22 49 21 309, e-mail: ndl@urpl.gov.pl

• 5. How to store AlliofilStore at a temperature not exceeding 25°C. Store in a place inaccessible and invisible to children.

Do not use Alliofil after the expiry date stated on the packaging.
Medicines should not be disposed of via wastewater or household waste. A pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Package contents and other information

What Alliofilcontains
The active substances of the medicine are:
200 mg Allium sativum L., bulbus(garlic bulb) and 53.5 mg Urtica dioica L., folium(nettle leaf).
In addition, the medicine contains excipients: microcrystalline cellulose with anhydrous colloidal silica, magnesium stearate, povidone, sodium croscarmellose, methacrylic acid and ethyl acrylate copolymer, propylene glycol, indigo carmine E 132, quinoline yellow E 104.
What Alliofillooks like and what the package contains
Alliofil is in the form of enteric-coated tablets.
The available package contains 2 Al/PVC blisters of 15 tablets in a carton.

Marketing authorization holder and manufacturer

Polska
Poznańskie Zakłady Zielarskie „Herbapol” S.A.
ul. Towarowa 47-51, 61-896 Poznań
tel. + 48 61 886 18 00, fax +48 61 853 60 58

Date of last revision of the leaflet:

Label text on the immediate packaging (blister).

ALLIOFIL

Allii sativi bulbus +Urticae folium
enteric-coated tablet, 200mg +53.5 mg
Batch:
EXP:
Poznańskie Zakłady Zielarskie „Herbapol” S.A.

Text on the outer packaging (carton for blisters).

ALLIOFIL

Allii sativi bulbus +Urticae folium
200 mg + 53.5 mg
enteric-coated tablet
supports in upper respiratory tract infections
Product intended for adults.
30 pieces
Alliofil is a traditional herbal medicinal product, whose indications are based solely on its long-term use. A doctor should be consulted if symptoms do not improve during the use of the product or if side effects not listed in the leaflet occur.

Composition:

Active substances: 1 tablet contains: powdered garlic bulb (Allii sativi bulbus) 200 mg;
powdered nettle leaf (Urticae folium) 53.5 mg.

Method of administration and route of administration:

For the prevention of upper respiratory tract infections: adults 3 times a day, 1 tablet.
As a supportive treatment for mild upper respiratory tract infections (common cold): adults 3 times a day, 1 to 3 tablets. The medicine should be taken after main meals.
Medicine available without a prescription – OTC.
The medicine should be stored in a place inaccessible and invisible to children.
Store at a temperature not exceeding 25°C.
Expiry date (EXP):

Marketing authorization holder:

Poznańskie Zakłady Zielarskie „Herbapol” S.A.
ul. Towarowa 47-51, 61-896 Poznań
Batch number (Lot):
Authorization number R/0062
EAN UCC code:
Product name in Braille